Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
April 30, 2024 08:38 ET
|
Fractyl Health, Inc.
Fractyl Health Announces Multiple Presentations at DDW 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
German American Bancorp, Inc. (GABC) Reports First Quarter 2024 Earnings
April 29, 2024 16:30 ET
|
German American Bancorp, Inc.
JASPER, Ind., April 29, 2024 (GLOBE NEWSWIRE) -- German American Bancorp, Inc. (Nasdaq: GABC) reported first quarter 2024 earnings of $19.0 million, or $0.64 per share, compared to earnings of $21.5...
Discover the Future of Crypto with Mooner Hive: Your Gateway to Newly Launched Tokens and Earned Rewards.
April 29, 2024 09:30 ET
|
Mooner Hive
Zurich, Switzerland , April 29, 2024 (GLOBE NEWSWIRE) -- Mooner Hive, the premier platform for newly launched cryptocurrency token listings and crypto earnings, is revolutionizing the way investors...
NORTHSHORE HEALTH CENTERS ANNOUNCES MERGER WITH OBSTETRICAL & GYNECOLOGICAL ASSOCIATES
April 23, 2024 10:00 ET
|
NorthShore Health
MUNSTER, Ind., April 23, 2024 (GLOBE NEWSWIRE) -- NorthShore Health Centers and Obstetrical & Gynecological Associates have merged to create a more comprehensive healthcare experience for...
Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
April 22, 2024 07:30 ET
|
Lexeo Therapeutics
Lexeo Therapeutics gains intellectual property rights including current and future clinical data from ongoing Weill Cornell Medicine investigator-initiated trial of gene therapy candidate AAVrh.10hFXN...
Enphase Energy Launches IQ Combiner Lite for Social Housing in the Netherlands
April 18, 2024 08:00 ET
|
Enphase Energy, Inc.
FREMONT, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery...
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
April 16, 2024 07:30 ET
|
Lexeo Therapeutics
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006
Cityview Completes 243-Unit Multifamily Project in Los Angeles’ Historic Filipinotown
April 11, 2024 11:00 ET
|
Cityview
Cityview has completed Belle on Bev – a 243-unit mixed-use project in Los Angeles’ Historic Filipinotown
Transgene et NEC présentent les premiers signes de bénéfice clinique de leur vaccin individualisé contre le cancer, TG4050, dans les cancers de la tête et du cou à l’AACR 2024
April 09, 2024 11:45 ET
|
Transgene S.A.
Les nouvelles données immunologiques de Phase I confirment la forte immunogénicité de TG4050 dans le traitement adjuvant des cancers de la tête et du cou.Tous les patients traités sont encore en...
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
April 09, 2024 11:45 ET
|
Transgene S.A.
Extensive Phase I immunology data confirm strong immunogenicity of TG4050 in the adjuvant treatment of head and neck cancers. All treated patients remain disease-free after a median follow-up of...